Journal of the European Academy of Dermatology and Venereology

Papers
(The H4-Index of Journal of the European Academy of Dermatology and Venereology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Announcement372
Editor's Picks January 2024243
Announcement239
126
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens119
Announcement115
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV114
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab113
Reply to comments by Tadulewicz and Muklewicz on socio‐economic outcomes of atopic dermatitis104
Louis Adolphus Duhring: An enduring legacy100
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis97
Advances in biologic therapy of psoriasis87
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis82
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic78
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer74
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa74
Are non‐fungible tokens the barrier to realizing the Dermoverse?72
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna71
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives69
Hand–foot syndrome like eruption following mRNA COVID‐19 vaccine68
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’66
Impact of menopause on the skin…information still insufficient65
62
Issue Information62
61
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization58
Announcement58
The affliction of job, as painted by Jusepe de Ribera: A dermatological observation going back to the 17th century57
Announcement57
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.56
Juvenile localized scleroderma: A single‐centre experience from India55
Dalbavancin for the treatment of severe hidradenitis suppurativa55
The chicken or the egg of lymphopenia in atopic eczema54
A case of eruptive halo nevi following COVID‐1954
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report53
Pharmacovigilance: The responsibility of all51
The future of digital pills and their potential use in dermatological clinical trials51
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction50
Rituximab in immunobullous disorders during the COVID‐19 pandemic: A systematic review of observational studies49
Educational, labour market and relationship outcomes in people with acne49
Editor’s Picks June 202549
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient48
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study45
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study44
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry44
0.15624403953552